ANDA 40781, held by Am Regent. Phenytoin Sodium.
As of Nov 16, 2026, ANDA 40781 (Phenytoin Sodium), held by Am Regent, was first approved by FDA on Dec 4, 2007, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 4, 2007 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phenytoin Sodium50MG/ML · injectable;injection | Phenytoin Sodium | Discontinued |
| Feb 16, 2021 | Supplement 7Labeling · Standard review | Approved | None posted |
| Jan 22, 2021 | Supplement 6Labeling · Standard review | Approved | None posted |
| Oct 5, 2015 | Supplement 2Labeling · Standard review | Approved | None posted |
| Oct 5, 2015 | Supplement 4Labeling · Standard review | Approved | None posted |
| Oct 5, 2015 | Supplement 5Labeling · Standard review | Approved | None posted |
| Dec 4, 2007 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters